$2.990
+0.158 (+5.28%)收盤時
ENTO 資訊
ENTO 事件
Entero Therapeutics Rebrands as GridAI
Entero Therapeutics will change its name to GridAI Technologies Corp., effective at 12:01 Eastern Time on Monday, December 1, 2025. The name change closely aligns the Company's business following its acquisition of 100% of GRID AI, a grid-edge, AI-driven software and controls platform that enables utilities, retail energy providers, and large power users to dynamically manage load and distributed energy resources including battery energy storage systems. In connection with the name change, the Company will change its ticker symbol to "GRDX". The Company's common stock will commence trading on the Nasdaq Capital Market exchange under the new name and trading symbol on December 1, 2025. The name and future ticker change do not affect the Company's legal structure, business operations, or existing financial reporting obligations. Shareholders are not required to take any action in connection with the change.
Entero Therapeutics' Grid AI is in the process of forming its U.S. leadership team.
Entero Therapeutics announced that its wholly owned subsidiary, Grid AI, is finalizing the establishment of a U.S.-based leadership team composed of highly accomplished executives from the energy, power, and technology sectors. This marks a significant step in Grid AI's expansion into the rapidly growing U.S. market for AI-ready digital infrastructure and orchestration technology. Entero expects to announce the appointment of a U.S.-based Chief Executive Officer and an Executive Chairman for Grid AI in the near term. The incoming executive team brings deep public-markets experience, including having grown and led a global, publicly traded company in the demand-response and energy-flexibility sector. Their leadership track record is directly aligned with Grid AI's strategy to integrate AI orchestration, energy optimization, and digital infrastructure controls across major hyperscale and enterprise AI deployments.
Entero Therapeutics Enters LOI to Merge LV Grid Team with Grid AI
Entero Therapeutics announced the signing of a Letter of Intent to integrate the LV Grid engineering team and related intellectual property into Grid AI. The company believes the addition of LV Grid marks a critical step in Grid AI's strategy to capture a leading position in the rapidly expanding AI data-center energy-orchestration market. Under the proposed structure, LV Grid's team, recognized for its deep experience in controls and energy optimization software, will join Grid AI to lead development of its AI Data Center Controls division. The team's prior tenure with a Grid AI predecessor ensures seamless integration and further enhances execution capability. Together, an integrated digital-dispatch and campus-optimization engine will be delivered, beginning with a soon-to-be-announced AI data center energy park in Texas, a flagship Grid AI deployment designed to validate the economics of fully orchestrated behind-the-meter generation and storage for hyperscale operators.
Entero Therapeutics Introduces Grid AI Corp.
Entero Therapeutics launches Grid AI Corp., to redefine how artificial intelligence infrastructure connects to the power grid. According to the company, the rise of artificial intelligence is driving the fastest infrastructure build-out in modern history and power is the new bottleneck. Over the next decade, global data center electricity demand is projected to exceed 1,000 terawatt-hours annually, with AI workloads alone representing over 30% of that growth. Analysts now estimate that more than $1T in new energy and digital infrastructure investment will be required to sustain AI's exponential trajectory. Yet across every major market, power delivery constraints threaten to delay or derail this growth. Grid AI Corp., is orchestrating, managing, and dispatching flexible data center loads, Grid AI transforms data centers from static consumers of electricity into dynamic, intelligent grid assets. The company's platform enables real-time coordination between compute demand and grid conditions, unlocking stranded capacity, reducing interconnection timelines, and accelerating AI infrastructure deployment by years. Grid AI's solutions can help unlock gigawatts of incremental grid capacity across North America and beyond, allowing data centers, utilities, and investors to scale faster, cleaner, and more profitably.
Entero Therapeutics files to sell 16.67M shares of common stock
Entero is offering 16.67M shares of common stock, and estimates that the public offering price will be 36c per share, based on the sale price of its common stock on The Nasdaq Capital Market on May 2. Westpark Capital is acting as the sole book-runner for the offering.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。